Research Topics
| Jens BuentzelSummaryAffiliation: Head and Neck Surgery Country: Germany Publications
| Collaborators |
Detail Information
Publications
Tumor markers and lymphatic metastasis in head and neck cancer patientsJens Büntzel
Department of Otolaryngology, Head Neck Surgery, Sudharzkrankenhaus Nordhausen, 99734 Nordhausen, Germany
Anticancer Res 25:1539-42. 2005..This study was conducted to evaluate the relationship between the lymph node status and tumor marker status in patients with histologically confirmed head and neck cancer...- Selenium substitution during radiotherapy of solid tumours - laboratory data from two observation studies in gynaecological and head and neck cancer patientsJens Büntzel
Department of Otolaryngology, Head Neck Surgery, Suedharz Krankenhaus, Nordhausen gGmbH, Nordhausen, Germany
Anticancer Res 30:1783-6. 2010..A reduced activity of GSH-Px is related to increased toxicities due to radiation therapy during primary cancer treatment. Therefore, selenium substitution may be a new supportive strategy to diminish radiation-associated side effects... - Nutritional parameters for patients with head and neck cancerJens Büntzel
Department of Otolaryngology, Head Neck Surgery, Südharz Hospital, Nordhausen, Germany
Anticancer Res 32:2119-23. 2012..Determination of the optimal nutritional parameter to provide useful information for the individual patient and assessing the impact of nutritional status have on the prognosis of head and neck cancer... - Serum selenium in head and neck cancer patients--a new marker of tumor activity?Jens Büntzel
Department of Otolaryngology, Head Neck Surgery, Sudharzkrankenhaus Nordhausen, 99734 Nordhausen, Germany
Anticancer Res 25:1711-2. 2005..The purpose of this work was to investigate the relationship between the tumor volume and the endogenous selenium levels in untreated head and neck cancer patients... - Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III studyJens Buentzel
Department of Otolaryngology, Head and Neck Surgery, Suedharzkrankenhaus Nodhausen, Nordhausen, Germany
Int J Radiat Oncol Biol Phys 64:684-91. 2006..This randomized, double-blinded, placebo-controlled, phase III study evaluated the efficacy and safety of i.v. amifostine during radiochemotherapy for head-and-neck cancer... - Zinc concentrations in serum during head and neck cancer progressionJens Büntzel
Department of Otolaryngology, Head and Neck Surgery, Sudharzkrankenhaus Nordhausen, Nordhausen, Germany
Anticancer Res 27:1941-3. 2007..Reduced serum-zinc concentrations are well known as typical laboratory characteristics in advanced head and neck cancer. Our aim was to follow the development of this phenomenon during the disease... - Influence of amifostine on late radiation-toxicity in head and neck cancer--a follow-up studyJens Büntzel
Department of Otolaryngology, Head and Neck Surgery, Sudharzkrankenhaus Nordhausen, Nordhausen, Germany
Anticancer Res 27:1953-6. 2007..The late toxicities due to multimodal therapy of advanced head and neck cancers were analysed. The impact of cytoprotection with amifostine is the specific objective of this report... - Limited effects of selenium substitution in the prevention of radiation-associated toxicities. results of a randomized study in head and neck cancer patientsJ Buntzel
Department of Otolaryngology, Head Neck Surgery, Sudharz Krankenhaus Nordhausen, Nordhausen, Germany
Anticancer Res 30:1829-32. 2010..g. irradiation or chemotherapy, and therefore the objective of this study was to investigate the clinical impact of selenium in such therapies... 
[Inappropriate and insufficient nutrition in ENT tumors]J Buntzel
Klinik für HNO Krankheiten, Kopf Hals Chirurgie, Südharz Krankenhaus Nordhausen gGmbH, Dr Robert Koch Str 39, 99734, Nordhausen, Deutschland
HNO 59:1139-47; quiz 1148-9. 2011..Partial or total parenteral nutrition (central venous access) should be restricted to crisis interventions or fast-track regimens...